$55.51 Last:
2.47% Change Percent:
$54.2 Open:
$55.51 Previous Close:
$55.84 High:
$54.02 Low:
4,954,076 Volume:
09/25/2020 04:55:24 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2020-09-25 | 54.2 | 55.51 | 55.84 | 54.02 | 4,954,076 |
2020-09-24 | 54.94 | 54.17 | 55.16 | 53.92 | 4,105,524 |
2020-09-23 | 56.22 | 55.66 | 56.585 | 55.575 | 2,921,256 |
2020-09-22 | 55.29 | 55.44 | 55.62 | 54.72 | 3,875,256 |
2020-09-21 | 55.09 | 55.91 | 55.91 | 54.62 | 6,790,555 |
2020-09-18 | 56.76 | 56.45 | 56.8 | 55.96 | 2,917,700 |
2020-09-17 | 55.74 | 55.94 | 56.15 | 55.49 | 3,988,831 |
2020-09-16 | 55.72 | 55.13 | 55.98 | 55.11 | 3,947,483 |
2020-09-15 | 55.53 | 55.28 | 55.78 | 55.1215 | 4,293,772 |
2020-09-14 | 54.23 | 54.02 | 54.34 | 53.37 | 4,957,099 |
2020-09-11 | 53.99 | 53.73 | 54.15 | 53.405 | 4,622,922 |
2020-09-10 | 54.16 | 53.07 | 54.19 | 53.04 | 4,395,719 |
2020-09-09 | 53.83 | 53.64 | 54.82 | 53.34 | 11,393,183 |
2020-09-08 | 54.14 | 54.71 | 54.94 | 53.76 | 6,061,847 |
2020-09-07 | 53.79 | 53.58 | 54.14 | 52.57 | 4,610,026 |
2020-09-04 | 53.79 | 53.58 | 54.14 | 52.57 | 4,604,146 |
2020-09-03 | 55.35 | 54.16 | 55.5 | 53.61 | 5,103,499 |
2020-09-02 | 55.47 | 55.9 | 55.99 | 55.27 | 3,597,085 |
2020-09-01 | 55.85 | 55.38 | 55.9 | 55.12 | 3,924,166 |
2020-08-31 | 55.8 | 56 | 56.34 | 55.61 | 3,162,291 |
Astrazeneca PLC Company Name:
AZN Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
ENHERTU ® (fam-trastuzumab deruxtecan-nxki) data will show the potential to improve survival for metastatic breast cancer patients and define a new segment of HER2-low disease Results from multiple trials further reinforce strength of industry-leading portfo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Each of these stocks to buy are low-beta stocks with attractive dividend yields to help endure a recession. AstraZeneca ( AZN ): Strong growth visibility with a deep pipeline of drug candidates. A healthy dividend ...
First time an albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations MANDALA Phase III trial results published in the New England Journal of Medicine and presented at ATS 2022 International Conference Full ...